Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(OP:CBIH)

0.0004 UNCHANGED
Streaming Delayed Price Updated: 2:15 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about CBIH

News headline image
Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions ↗
As rates of pancreatic and breast cancer increase among the population, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) opted to address the infamous trend with new treatment methodologies.... 
Via Benzinga
Topics Cannabis Intellectual Property
News headline image
Texas Cannabis Company Secures $2B Valuation From LA Financial Firm ↗
Texas cannabis research firm CBIH secures $2 billion valuation after strategic revamp. Valuation fuels growth plans. Read now! 
Via Benzinga
Topics Cannabis
News headline image
Executive Changes In Marijuana Industry You Should Know About, New Cannabis Appointments & More ↗
Slightly over a year following Gov. Dan McKee's decision to appoint three experts to the Cannabis Control Commission with a task to regulate, license and control the medical and recreational cannabis... 
Via Benzinga
Topics Cannabis
News headline image
Who's Who In Cannabis: Latest Executive Changes You Should Know About ↗
 
Via Benzinga
News headline image
SEC Green Lights Public Listing Of Texas Cannabis Co. That Will Use AI In Clinical Trials ↗
Cannabis Bioscience, a Houston-based clinical research company, has announced plans to conduct cannabis clinical trials using artificial intelligence (AI) programs. The company aims to optimize the... 
Via Benzinga
Topics Artificial Intelligence Cannabis Regulatory Compliance
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.